ATE209191T1 - Parazinon thrombin inhibitoren - Google Patents
Parazinon thrombin inhibitorenInfo
- Publication number
- ATE209191T1 ATE209191T1 AT97918780T AT97918780T ATE209191T1 AT E209191 T1 ATE209191 T1 AT E209191T1 AT 97918780 T AT97918780 T AT 97918780T AT 97918780 T AT97918780 T AT 97918780T AT E209191 T1 ATE209191 T1 AT E209191T1
- Authority
- AT
- Austria
- Prior art keywords
- parazinone
- thrombin inhibitors
- thrombin
- inhibitors
- compounds
- Prior art date
Links
- 229940122388 Thrombin inhibitor Drugs 0.000 title 1
- 239000003868 thrombin inhibitor Substances 0.000 title 1
- 108090000190 Thrombin Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 229960004072 thrombin Drugs 0.000 abstract 1
- 230000001732 thrombotic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/20—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1604196P | 1996-04-23 | 1996-04-23 | |
| GBGB9609714.2A GB9609714D0 (en) | 1996-05-09 | 1996-05-09 | Pyridinone thrombin inhibitors |
| US4300997P | 1997-04-14 | 1997-04-14 | |
| PCT/US1997/006744 WO1997040024A1 (en) | 1996-04-23 | 1997-04-18 | Pyrazinone thrombin inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE209191T1 true ATE209191T1 (de) | 2001-12-15 |
Family
ID=27268274
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97918780T ATE209191T1 (de) | 1996-04-23 | 1997-04-18 | Parazinon thrombin inhibitoren |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0900207B1 (de) |
| JP (1) | JP3140790B2 (de) |
| KR (1) | KR20000010650A (de) |
| AT (1) | ATE209191T1 (de) |
| AU (1) | AU714985B2 (de) |
| BG (1) | BG102948A (de) |
| BR (1) | BR9708859A (de) |
| CA (1) | CA2252964A1 (de) |
| CZ (1) | CZ340898A3 (de) |
| DE (1) | DE69709727T2 (de) |
| EE (1) | EE9800353A (de) |
| HR (1) | HRP970211A2 (de) |
| IL (1) | IL126404A0 (de) |
| IS (1) | IS4853A (de) |
| NO (1) | NO984928L (de) |
| NZ (1) | NZ331993A (de) |
| PE (1) | PE13399A1 (de) |
| PL (1) | PL329441A1 (de) |
| SK (1) | SK145398A3 (de) |
| TR (1) | TR199802133T2 (de) |
| WO (1) | WO1997040024A1 (de) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU746024B2 (en) * | 1996-04-23 | 2002-04-11 | Merck & Co., Inc. | Pyrazinone thrombin inhibitors |
| EP0927171B1 (de) | 1996-09-16 | 2002-02-20 | Du Pont Pharmaceuticals Company | Eine resorbierbare röntgenopake markierung enthaltendes chirurgisches implantat und verfahren zum verriegeln desselben in einem körper |
| EP0969840A4 (de) * | 1997-03-24 | 2001-02-28 | Merck & Co Inc | Thrombin inhibitoren |
| US6011038A (en) * | 1997-09-05 | 2000-01-04 | Merck & Co., Inc. | Pyrazinone thrombin inhibitors |
| EP1079835A4 (de) * | 1998-05-19 | 2002-10-29 | Merck & Co Inc | Pyrazinone als thrombininhibitoren |
| US6147078A (en) * | 1998-05-19 | 2000-11-14 | Merck & Co., Inc. | Pyrazinone thrombin inhibitors |
| WO1999061442A1 (en) * | 1998-05-26 | 1999-12-02 | Merck & Co., Inc. | Imidazopyridine thrombin inhibitors |
| JP4554077B2 (ja) | 1998-06-11 | 2010-09-29 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | ピラジノンプロテアーゼインヒビター |
| PT997474E (pt) | 1998-08-14 | 2004-01-30 | Pfizer | Agentes antitromboticos |
| CA2343109A1 (en) * | 1998-09-28 | 2000-04-06 | Merck & Co., Inc. | Thrombin inhibitors |
| CA2348734A1 (en) | 1998-10-30 | 2000-05-11 | Merck & Co., Inc. | Thrombin inhibitors |
| CA2348530A1 (en) | 1998-10-30 | 2000-05-11 | Merck & Co., Inc. | Thrombin inhibitors |
| EP1140862A4 (de) | 1998-12-23 | 2004-07-28 | Bristol Myers Squibb Pharma Co | Inhibitoren von thrombin oder faktor-xa |
| AR023510A1 (es) | 1999-04-21 | 2002-09-04 | Astrazeneca Ab | Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina. |
| US6716838B1 (en) | 1999-05-19 | 2004-04-06 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents |
| US7015230B1 (en) | 1999-05-19 | 2006-03-21 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade |
| US6750342B1 (en) | 1999-05-19 | 2004-06-15 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade |
| US6664255B1 (en) * | 1999-05-19 | 2003-12-16 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
| IL146245A0 (en) * | 1999-05-19 | 2002-07-25 | Pharmacia Corp | Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
| US6458952B1 (en) | 1999-05-19 | 2002-10-01 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade |
| US6867217B1 (en) | 1999-05-19 | 2005-03-15 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade |
| US6653316B1 (en) | 1999-05-19 | 2003-11-25 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade |
| EP1586565A1 (de) * | 1999-05-19 | 2005-10-19 | Pharmacia Corporation | Substituierte polycyclische aryl und heteroarylpyrazinone zur selektiven Hemmung von der Blutgerinnungskaskade |
| UA58636C2 (uk) * | 1999-06-04 | 2003-08-15 | Мерк Енд Ко., Інк. | Піразинонові інгібітори тромбіну, фармацевтична композиція, спосіб інгібування утворення тромбів у крові, спосіб лікування станів, пов'язаних із тромбоутворенням |
| AU773317B2 (en) * | 1999-07-19 | 2004-05-20 | Merck Canada Inc. | Pyrazinones, compositions containing such compounds |
| JP2003514905A (ja) | 1999-11-23 | 2003-04-22 | メルク エンド カムパニー インコーポレーテッド | ピラジノン系トロンビン阻害薬 |
| AU2001243598A1 (en) | 2000-03-13 | 2001-09-24 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade |
| EP1267876A1 (de) | 2000-03-23 | 2003-01-02 | Merck & Co., Inc. | Thrombinhemmer |
| CA2405306A1 (en) | 2000-04-05 | 2001-10-18 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade |
| JP2004505014A (ja) | 2000-04-05 | 2004-02-19 | ファルマシア・コーポレーション | 凝血カスケードの選択的阻害に有用な多環式アリールおよびヘテロアリール置換された４−ピロン類 |
| WO2001079193A2 (en) * | 2000-04-14 | 2001-10-25 | Corvas International, Inc. | Substituted hydrazinyl heteroaromatic inhibitors of thrombin |
| US6506761B1 (en) | 2000-04-14 | 2003-01-14 | Corvas International, Inc. | Substituted hydrazinyl heteroaromatic inhibitors of thrombin |
| US6506760B1 (en) | 2000-04-14 | 2003-01-14 | Corvas International, Inc. | Substituted hydrazinyl heteroaromatic inhibitors of thrombin |
| CA2405684A1 (en) | 2000-04-17 | 2001-10-25 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted 1,4-quinones useful for selective inhibition of the coagulation cascade |
| EP1303510A2 (de) * | 2000-07-17 | 2003-04-23 | 3-Dimensional Pharmaceuticals, Inc. | Cyclische oxyguanidin-pyrazinone als protease-hemmer |
| US6710058B2 (en) | 2000-11-06 | 2004-03-23 | Bristol-Myers Squibb Pharma Company | Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors |
| EP1351686A2 (de) | 2000-11-20 | 2003-10-15 | Pharmacia Corporation | Substituierte polycyclische aryl- und heteroarylpyridine für die selektive hemmung der koagulationskaskade |
| US7015223B1 (en) | 2000-11-20 | 2006-03-21 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade |
| US7119094B1 (en) | 2000-11-20 | 2006-10-10 | Warner-Lambert Company | Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade |
| WO2003029216A1 (en) | 2001-10-03 | 2003-04-10 | Pharmacia Corporation | 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| US7105559B2 (en) | 2001-10-03 | 2006-09-12 | Pharmacia Corporation | Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
| CN100486576C (zh) | 2002-02-14 | 2009-05-13 | 法玛西雅公司 | 作为p38map激酶调节剂的取代吡啶酮类 |
| GB0306615D0 (en) * | 2003-03-22 | 2003-04-30 | Astrazeneca Ab | New use |
| EP1526131A1 (de) * | 2003-10-22 | 2005-04-27 | Graffinity Pharmaceuticals Aktiengesellschaft | Aminoalkyl-Pyrazinone und -Pyridone verwendbar als Thrombininhibitoren |
| GB0507577D0 (en) | 2005-04-14 | 2005-05-18 | Novartis Ag | Organic compounds |
| BRPI0612045A2 (pt) * | 2005-06-17 | 2018-07-24 | Astrazeneca Ab | composto, formulação farmacêutica, uso de um composto, método de tratamento de uma condição, e, processo para preparação de um composto |
| WO2017067670A1 (en) | 2015-10-23 | 2017-04-27 | Pharmathen S.A. | A novel process for the preparation of tryptamines and derivatives thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE71096T1 (de) * | 1986-09-26 | 1992-01-15 | Ciba Geigy Ag | Aminopyrazinone und aminotriazinone. |
-
1997
- 1997-04-18 CZ CZ983408A patent/CZ340898A3/cs unknown
- 1997-04-18 WO PCT/US1997/006744 patent/WO1997040024A1/en not_active Ceased
- 1997-04-18 JP JP09538296A patent/JP3140790B2/ja not_active Expired - Fee Related
- 1997-04-18 BR BR9708859A patent/BR9708859A/pt not_active Application Discontinuation
- 1997-04-18 CA CA002252964A patent/CA2252964A1/en not_active Abandoned
- 1997-04-18 KR KR1019980708609A patent/KR20000010650A/ko not_active Withdrawn
- 1997-04-18 NZ NZ331993A patent/NZ331993A/xx unknown
- 1997-04-18 DE DE69709727T patent/DE69709727T2/de not_active Expired - Fee Related
- 1997-04-18 AT AT97918780T patent/ATE209191T1/de active
- 1997-04-18 TR TR1998/02133T patent/TR199802133T2/xx unknown
- 1997-04-18 PL PL97329441A patent/PL329441A1/xx unknown
- 1997-04-18 SK SK1453-98A patent/SK145398A3/sk unknown
- 1997-04-18 EP EP97918780A patent/EP0900207B1/de not_active Expired - Lifetime
- 1997-04-18 EE EE9800353A patent/EE9800353A/xx unknown
- 1997-04-18 IL IL12640497A patent/IL126404A0/xx unknown
- 1997-04-18 AU AU26799/97A patent/AU714985B2/en not_active Ceased
- 1997-04-21 HR HR60/043,009A patent/HRP970211A2/xx not_active Application Discontinuation
- 1997-04-23 PE PE1997000308A patent/PE13399A1/es not_active Application Discontinuation
-
1998
- 1998-09-25 IS IS4853A patent/IS4853A/is unknown
- 1998-10-22 NO NO984928A patent/NO984928L/no unknown
- 1998-11-23 BG BG102948A patent/BG102948A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2000508334A (ja) | 2000-07-04 |
| IS4853A (is) | 1998-09-25 |
| IL126404A0 (en) | 1999-05-09 |
| WO1997040024A1 (en) | 1997-10-30 |
| DE69709727D1 (de) | 2002-02-21 |
| PL329441A1 (en) | 1999-03-29 |
| EP0900207B1 (de) | 2001-11-21 |
| HRP970211A2 (en) | 1998-06-30 |
| NO984928L (no) | 1998-12-22 |
| EE9800353A (et) | 1999-04-15 |
| DE69709727T2 (de) | 2002-08-08 |
| KR20000010650A (ko) | 2000-02-25 |
| BG102948A (bg) | 1999-11-30 |
| JP3140790B2 (ja) | 2001-03-05 |
| AU714985B2 (en) | 2000-01-13 |
| NO984928D0 (no) | 1998-10-22 |
| CA2252964A1 (en) | 1997-10-30 |
| NZ331993A (en) | 2000-04-28 |
| SK145398A3 (en) | 1999-05-07 |
| AU2679997A (en) | 1997-11-12 |
| TR199802133T2 (xx) | 2000-09-21 |
| CZ340898A3 (cs) | 1999-02-17 |
| EP0900207A1 (de) | 1999-03-10 |
| BR9708859A (pt) | 1999-08-03 |
| PE13399A1 (es) | 1999-02-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE209191T1 (de) | Parazinon thrombin inhibitoren | |
| WO1996003374A1 (en) | Thrombin inhibitors | |
| ATE234091T1 (de) | Thrombin inhibitoren | |
| DE69620161D1 (de) | Thrombininhibitoren | |
| ATE291031T1 (de) | Medikamenten-vorstufen für thrombin-inhibitoren | |
| DE69828682D1 (de) | Nanomolare, non-peptidische inhibitoren von cathepsin d | |
| TR199800773T2 (xx) | Trombin inhibit�rleri. | |
| FI973282A7 (fi) | Trombiinin inhibiittoreita | |
| ID18142A (id) | Inhibitor metaloprotease 1,4-heterosiklik | |
| ID18141A (id) | Inhibitor metaloprotease 1,3-diheterosiklik | |
| ATE268781T1 (de) | Thrombininhibitoren | |
| ATE228760T1 (de) | Thrombininhibitoren | |
| EE9800044A (et) | Prolüülendopeptidaasi inhibiitorid | |
| ZA974779B (en) | Thrombin inhibitors. | |
| DE69731664D1 (de) | Thrombininhibitoren | |
| ATE227571T1 (de) | Thrombin inhibitoren | |
| ZA961276B (en) | Novel thrombin inhibitors. | |
| ECSP972090A (es) | Inhibidores de trombina pirazinona | |
| ITMI930102A0 (it) | Inibitori della trombina |